Researchers develop a new strategy to 3D print bone-mimicking structures at room temperature incorporating live, bone-forming cells.
Vaccinating the most vulnerable first may not have the greatest impact on COVID-19, new model suggests
A new simulator can accurately model COVID-19 and the effects of different mitigation strategies, which researchers say could help guide new policies to combat the pandemic.
New method to assist fast-tracking of vaccines for pre-clinical tests
Nvel tuberculosis vaccine demonstrated strong immune response in mice.
Phages help reverse antibiotic resistance in dangerous superbug
Scientists investigated phages that can kill the world’s leading superbug, Acinetobacter baumannii, which is responsible for up to 20% of infections in intensive care units.
How do viruses protect their genetic information?
Researchers uncover the mystery of how viruses avoid encapsulating unwanted genetic material from the crowded cell cytoplasm.
The first COVID-19 vaccines are here, but challenges remain
Whilst vaccines against COVID-19 show there is light at the end of the tunnel, three main challenges still need to be addressed.
New macrocycle antiviral drugs show promise in treating influenza
Creating antiviral drugs to help treat infected patients is more important than ever. Now, researchers report a non-toxic macrocycle antiviral agent that shows high efficacy against several influenza strains.
Oxford–AstraZeneca COVID-19 vaccine shown to be safe and effective
The results of the company’s COVID-19 vaccine clinical trials are the first to be published in a peer-reviewed journal.
Pfizer/BioNTech vaccine approved in the UK for immediate emergency use
The companies announce the first emergency approval of their mRNA vaccine against COVID-19, with rollout to begin next week.
Scientists discover role of protein in detecting the common cold virus
Scientists uncover how a sensor protein activates our immune system against the common cold. The findings may lead to more effective treatments of flu-like symptoms.